Combining gamma-tocopherol and aspirin synergistically suppresses colitis-associated colon tumorigenesis and modulates the gut microbiota in mice, and inhibits the growth of human colon cancer cells
European Journal of Pharmacology · 2023
DOI: 10.1016/j.ejphar.2023.175656 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2023. Verfasst von Kilia Y Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Science, Purdue University, West Lafayette, IN, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colonic Neoplasms, Colitis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Institutes of Health, U.S. Department of Agriculture, Purdue Research Foundation.
Abstract (Originalsprache)
Despite being shown to be effective for chemoprevention of colorectal cancer, aspirin has limitations including adverse effects and inability to block colitis-associated colon cancer (CAC). γ-Tocopherol (γT), a vitamin E form, has been reported to mitigate experimental colitis and CAC, prolong the anti-inflammatory activity of aspirin and alleviate aspirin-induced adverse effect. We therefore hypothesize that combining γT and aspirin is better than either compound singly for suppressing CAC. This hypothesis was tested in the murine azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced CAC model and with human HCT116 colon cancer cells. Compared to the control, combining aspirin (250 ppm) and γT (500 ppm) but not either compound alone significantly reduced AOM/DSS-induced tumor area and multiplicity of large-size tumors by 60% and 50%, respectively. Meanwhile, γT mitigated aspirin-promoted inflammation and stomach lesions in mice. Moreover, the combination appeared to cause favorable changes of gut microbiota compared to the control and synergistically suppressed the growth of HCT116 cells. Our study demonstrates that combining aspirin and γT improves anticancer effects and counteracts side effects compared to aspirin and may therefore be a novel combinatory chemopreventive agent against CAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition Science, Purdue University, West Lafayette, IN, USA.
- Department of Agronomy, Purdue University, West Lafayette, IN, USA.
- Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA.
- Department of Nutrition Science, Purdue University, West Lafayette, IN, USA. Electronic address: qjiang@purdue.edu.
Förderung
- National Institutes of Health
- U.S. Department of Agriculture
- Purdue Research Foundation
- Purdue University Center for Cancer Research
Zitieren
APA
Liu, K. Y., Wang, Q., Nakatsu, C. H., Jones-Hall, Y., & Jiang, Q. (2023). Combining gamma-tocopherol and aspirin synergistically suppresses colitis-associated colon tumorigenesis and modulates the gut microbiota in mice, and inhibits the growth of human colon cancer cells. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2023.175656
Vancouver
Liu KY, Wang Q, Nakatsu CH, Jones-Hall Y, Jiang Q. Combining gamma-tocopherol and aspirin synergistically suppresses colitis-associated colon tumorigenesis and modulates the gut microbiota in mice, and inhibits the growth of human colon cancer cells. European Journal of Pharmacology. 2023. doi:10.1016/j.ejphar.2023.175656
BibTeX
@article{Liu2023,
author = {Liu, Kilia Y and Wang, Qianyue and Nakatsu, Cindy H and Jones-Hall, Yava and Jiang, Qing},
title = {Combining gamma-tocopherol and aspirin synergistically suppresses colitis-associated colon tumorigenesis and modulates the gut microbiota in mice, and inhibits the growth of human colon cancer cells},
journal = {European Journal of Pharmacology},
year = {2023},
doi = {10.1016/j.ejphar.2023.175656}
}
EUVIMED